Pediatr Neurol 1986, 2: 90-94
Son yllarda, haberlerde, sosyal medyada veya hatta arkadalarnzdan ve ailenizden GLP-1 ilalar hakknda daha ok ey duymu olabilirsiniz
Schmidts hope is that by interrupting these reward signals, GLP-1 medications can help a patient stop or reduce craving-induced relapse during withdrawal
New England Journal of Medicine , 391 (17), 15731583
Patients currently on semaglutide who have hit a weight loss plateau often see renewed progress when transitioning to tirzepatide, likely due to the additional GIP receptor activation
Many GLP-1 analogs have been shown to reduce the incidence and progression of diabetic nephropathy compared with the results obtained with the conventional therapy for patients with T2DM(Orsted et al., 2017)